uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 17, 2017

FDA Finds Problems at 62% of Supplement Manufacturing Sites in U.S. and Abroad has obtained results of the FDA's inspections in 2016 of 583 dietary supplement manufacturing facilities, showing that most -- 362 (62%) -- received letters indicating noncompliance with current Good Manufacturing Practices (cGMPs). Manufacturers are required by law to follow cGMPs, but only a small fraction of facilities are inspected by the FDA each year. 

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at